Skip to main content
. 2018 Mar 8;7(3):e152–e155. doi: 10.1093/jpids/piy022

Figure 1.

Figure 1.

Practice patterns among providers for the workup and treatment of osteomyelitis-associatedStaphylococcus aureus bacteremia (SAB). (A) Diagnostic workup for a child with osteomyelitis-associated SAB that is improving shortly after antibiotic initiation. Almost all providers repeat blood cultures until negative; however, the minority will routinely look for other foci of infection. (B) For the treatment of osteomyelitis-associated SAB, 50% of providers will switch to an oral regimen for nonpersistent bacteremia. Twenty-eight percent and 22% will treat with all intravenous antibiotics or treat with oral antibiotics after clinical improvement, respectively. (C) For the treatment methicillin-susceptibleStaphylococcus aureus bacteremia with osteomyelitis, 55% of clinicians use nafcillin, 42% use cefazolin, and 3% use an alternative agent.